AU661274B2 - Process and device for dosing powders - Google Patents

Process and device for dosing powders Download PDF

Info

Publication number
AU661274B2
AU661274B2 AU80638/91A AU8063891A AU661274B2 AU 661274 B2 AU661274 B2 AU 661274B2 AU 80638/91 A AU80638/91 A AU 80638/91A AU 8063891 A AU8063891 A AU 8063891A AU 661274 B2 AU661274 B2 AU 661274B2
Authority
AU
Australia
Prior art keywords
powder
carrier
charged
inhalation
fibres
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80638/91A
Other versions
AU8063891A (en
Inventor
Arun Rajaram Gupte
Dieter Hochrainer
Adolf Knecht
Gerhard Poss
Jurgen Wittekind
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4020571A external-priority patent/DE4020571A1/en
Priority claimed from DE19914102793 external-priority patent/DE4102793A1/en
Application filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU8063891A publication Critical patent/AU8063891A/en
Application granted granted Critical
Publication of AU661274B2 publication Critical patent/AU661274B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/26Methods or devices for controlling the quantity of the material fed or filled
    • B65B3/34Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations
    • B65B3/36Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations and arresting flow by cut-off means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0225Carbon oxides, e.g. Carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073Syringe, piston type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075Bulb type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8218Gas operated
    • A61M2205/8225Gas operated using incorporated gas cartridges for the driving gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Electrostatic Spraying Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nozzles (AREA)
  • Holding Or Fastening Of Disk On Rotational Shaft (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Refuse Collection And Transfer (AREA)
  • Vending Machines For Individual Products (AREA)
  • Disintegrating Or Milling (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In order to produce an aerosol, a velvety or velours-like material charged with a powder is brought into an air current.

Description

WELTORGANISATION FOJR GEISTIGES EIGENTUM Pcr Intemationales Baro INTERNATIONALE ANMELDUNG VEROFFENTLICHT NACH DEM VERTRAG OBER DIE INTERNATIONALE ZUSAMMENARBEIT AUF DEM GEBIET DES PATENTWESENS (PCT) (51) Internationale Patentkiassifikation 5: (11) Intet. .ionale Ver~ffentlichungsnummer: WO 92/00115 A61M 15/00, A61J 1/00 Al (43) Internationales A61M 13/00 Ver~ffentlichungsdatum: 9. .Januar 1992 (09.01.92) (21) Internationales Aktenzeichen: PCT/EP91/01 153 (81) Bestimmungsstanten: AT (europaisches Patent), AU, BE (europ~isches Patent), CA, CH (europgisches Patent), (22) Internationales Anmneldedatum: 21. Juni 1991(21.06.91) CS, DE (europaisches Patent), DK (europ~isches Patent), ES (europaisches Patent), FI, FR (europaisches Priori tiitsdaten: Patent), GB (europaisches Patent), GR (europ~isches P 40 20 57 1.1 28. Juni 1990 (28.06.90) DE Patent), HU, IT (europ~isches Patent), JP, KR, LU (eu- P 41 02 793.0 3 1. Januar 1991 (31.01.9 1) DE rop~isches Patent), NL (europaisches Patent), NO, PL, SE (europllisches Patent), SU, US.
(71) Anmnelder (nur fir AU CA GB): BOER RINGER INGEL- HEIM INTERNATIONAL GMBH [DE/DE]; Postfach 200, D-6507 Ingelheim Ver~ffentlicht Mit iniernationulem Recherchenbericht.
(71) Anmelder (ftir alle Bestimmungssraaten ausser AU CA GB US): BOEHRINGER INGELHEIM KG [DE/DE]; Postfach 200, D-6507 Ingelheimn (DE).
(72) Erfinder; und 617 Erfinder/Anmelder (nurjiir US) GUPTE, Arun, Rajaram [DE/DE]; Oestricher Str. 17, D-6507 Ingeiheim (DE).
HOCHRAINER, Dieter [DE/DE]; Hasengasse 8, D- 6530 B~ingen P055. Gerhard [DE/DE]; Zumn Buchenhain 16a, D-6905 Schriesheim WITTEKIND, Jiirgen [DE/DE]; Cranachstrage 20, D-6000 Frankfurt am Main 70 ZIERENBERG, Bernd [DE/DE]; Goethestrage 1, D-6530 Bingen KNECHT, Adolf [DE/DEB- I l7er Ebrenhof 5, D-6500 Mainz (DE).
(54)Title: PROCESS AND DEVICE FOR DOSING POWDERS (54) Bezeichnung: VORRICHTUNG UND VERFAHREN ZUR PULVERDOSIERUNG (57) Abstr-act 16 In order to produce an aerosol, a velvety or- velours- 15 12 1 like material charged with a powder is brought into an air current.
(57) Zusammenfassung Zur I e;eln ines A'erosols wird cirt mit ILulver beladenes velours- oder samltartiges Material in einen Luft- 1 strom gebracht. 13I 17 19 I lr*-rsYI -1- 56831J Process and device for dosing powders The invention relates to an apparatus and a process for metering small amounts of finely divided powder.
Small amounts of finely divided, preferably micronised powder are used particularly for therapeutic purposes, mainly in the form of aerosols for the treatment by inhalation of respiratory complaints such as asthma.
Powders of this kind are conveyed to the patient's lungs in amounts which are usually well below 50 mg in the air breathed in. It has been found that the particles of active substance should be less than 10 gm in size to ensure that they penetrate deep into the lungs. However, this does not rule out the use of some larger particles in the preparations, particularly for any excipients. If particles of different sizes are used, a significant difference in size is sometimes even desirable or in any case not harmful; cf. DE-OS 17 92 207.
Two main methods have been developed for administering fine powders without the aid of propellant gases in respiratory tract therapy.
One method makes use of hard gelatine capsules each of which contains a dose of active substance and possibly also excipients, whilst the other, using a measuring chamber, removes a specific amount of powder from a storage container and mixes it with the air breathed in. Devices for both methods have been described in large numbers, cf. for example DE-OS 23 46 914; EP-OS 166 294.
The invention now provides a new method of administering fine powders. In this method, the ease of manufacture of carriers charged with active substance is advantageously combined with accuracy of metering and -2the possibility of producing an aerosol suitable for inhalation by simple means.
In accordance with the present invention, therefore, there is provided a powder-charged carrier which is charged with a powdered pharmaceutical and which comprises a substantially flat velvet-like or velour-like material, and the powder is incorporated between fibres thereof. The velvet-like or velour-like material is charged with the powder, which is to be metered, and the desired amount of powder is blown down from the carrier by means of a gas jet, possibly after mechanical loosening, preferably using an air jet of suitable intensity. When used for inhalation, the powder released is mixed with the air breathed in, optionally via an inhalation device such as the one described, for example, in German Utility Model 89 08273.
When the dry powder is spread into the velvet-like or velour-like material, C C Sthe movement of the fibres under the doctor blade causes a preliminary break-up.
The particles are then in a very loose state and are correspondingly less inclined el*4 to clump together. When the powder is applied by means of a suspension, this preliminary break-up is achieved by running an edge over the powder, so that once again only some of the energy for the breaking-up has to be supplied by the gas So jet. Moreover, the previously broken up particles present a large surface area for o contact with the gas jet, which again has a favourable effect on dispersal.
Thus the movement of the fibres in a velvet-like or velour-like material may positively contribute to the breakdown of agglomerated areas of powder during the application of the powder to the carrier, and particularly to the efficacious dispersal of the powder from the carrier.
This is in contrast to the use of fabric or fleece-like carriers, or carriers with little low indentations, where the attempted use of a doctor-blade to spread the powder or of an edge to aid in the liberation of the powder may lead instead to. a detrimental compaction of the powder, thus inhibiting the dispersal of the powder from the carrier.
The carrier consists of a substantially planar material on which thin fibres are provided. The fibres are secured by one end or at the centre on or in the carrier, the free end or the two free ends being directed upwardly and the carrier 2315195.S6923.SPE 2a and fibres predominantly forming angles of from 450 to 90°, more particularly from 600 to 900 with one another. The material which carries the fibres may be, for example, paper, plastics film or a textile fabric; the fibres may be natural or synthetic, for example cotton, wool, silk, viscose, perlon, nylon or polyacrylic.
The fibres are up to about 3 mm long, preferably up to about 1 mm long.
They should not be too matted, to ensure that the powder applied, which is essentially o os 00a o0 0 00 o o 0 o j 0 0 :oo 0 06 I oI 9 0 o 3 embedded between the fibres, can be blown out again relatively easily. The lower limit for the length of the fibres is about 0.1 mm. Generally, the length of the fibres should be such that the powder applied can be accommodated in the desired quantities per unit of surface area.
Accordingly, a carrier material with longer fibres is appropriate for relatively large quantities of powder per unit of surface area, whereas, for very small quantities of powder per unit of surface area, shorter fibres are usable or, even, advantageous. The quantity of powder which can be applied per unit of surface area depends mainly on the nature (density) of the powder and its compaction, as well as the carrier material used.
If the powder is to be administered by inhalation, care must however be taken to ensure that the dispersal of the powder in the gas or air jet used is not affected by excessive compaction.
The number of fibres per unit of surface area may vary considerably. Various commercially available carriers have proved suitable (velour-film, velvet, niki). These products also provide a guide to the suitable fibre density of other carriers. The fibre thickness also varies within wide limits. Generally, fibres with a diameter of from 0.002 to 0.05, preferably 0.004 to 0.03 mm are used. The velvet-like carrier itself may also be attached, e.g. by glueing, to a stiff layer. It is also possible to attach an absorbent under-layer.
The carrier may be correspondingly flexible or rigid and rectangular or circular, for example.
Preferably, the carrier is in the form of a strip. This may be charged with the powder over its entire surface or over individual areas. In the latter case, the strip may be charged with the powder by means of a template over small individual areas, e.g. in the form of circular areas a few millimetres in diameter and clearly
I-
4 spaced apart, so that when the powder is blown out from one of these areas the powder on the neighbouring areas remains unaffected.
Thus, the dose can be accurately fixed by means of the quantity of powder on each of the small charged areas.
If the entire surface of the carrier is coated with powder, the quantity of powder which is blown out can simply be determined by the size of the area exposed to the gas jet during each separate removal operation and defined, for example, by means of a mask. However, a mask is not essential. It has been found, in fact, that the quantity of powder blown downwards from the uniformly charged carrier by means of the gas jet is substantially constant. Consequently, the quantity of powder dispersed can also be regulated by the intensity of the gas jet and the geometry of the nozzle.
In order to protect the layer of powder it may be appropriate to cover or laminate the carrier with a plastics film, for example, in such a way that only that part of the carrier from which powder is to be taken is exposed. Particularly in moisture-sensitive powders, an aluminium lamination on both sides might be considered.
Finally, it is also possible to use carriers, e.g.
strips, in which there are alternating areas filled with fibres and smooth areas.
In order to charge the carrier, first of all a layer of powder 1 to 2 mm high is distributed as uniformly as possible thereon (in the case of highly effective pharmaceutical powders and in the case of carriers with very short fibres the layer may be considerably thinner). The powder is pressed into the strip by means of a doctor blade and excess powder is wiped away. This process is repeated once or several times, as necessary, with the doctor blade being set progressively lower. As a result of the movement of the fibres under the pressure of the doctor blade, the
AIM
agglomerated areas of powder are broken up.
If only certain parts of the carrier are to be charged, the carrier may be covered, for example, with a template, e.g. a suitably perforated film. If the powder is then applied as described above, the carrier will be charged with it only at those points where the perforations are located.
The powder may also be applied to the carrier in the form of a suspension. In the case of pharmaceutical compositions for inhalation, the dosage of active substance is generally so small that the quantity of active substance contained in one drop of suspension is sufficient. One drop of the suspension is then applied at the desired spacing from the next drop. The spacing is selected so that the spot of powder which remains after evaporation of the suspension agent is clearly separated from the adjacent spot. The aim is to be able to separate only the exact quantity of powder applied in one drop from the carrier when the powdered active substance is transferred into the stream of air breathed in.
It is particularly satisfactory to charge the carrier with an accurately metered quantity of powder over a small area using a suspension.
The suspending agents used may be liquid organic compounds in which the powder to be applied does not dissolve readily and which can be eliminated as completely as possible.
Examples of suspending agents of this kind which are selected in accordance with the solubility characteristics of the substance or mixture of substances to be suspended include dichloromethane, ethyl acetate, l,l,l-trichloroethane or petrol the fraction 60/95 or 80/110). As a rule, suspension adjuvants such as lecithin are added to the suspension.
The solids content in the suspension is usually between 3 and 30 percent by weight, preferably from 5 to 4i o 6 percent by weight; the quantity of suspension adjuvants varies between about 0.5 and 3 percent by weight, based on the solids.
The carriers and suspension should be such that the particles of powder are left behind at the point where the drop penetrates into the carrier, whilst the suspending agent spreads out and then evaporates. The evaporation can be promoted by pressure reduction and/or by heating.
The material from the dried drop of suspension cannot generally be released and dispersed simply by means of a jet of air. However, if the fibres of the carrier are moved, e.g. by running an edge over them, the bonds between the particles of powder are broken up again and the powder is "activated". The individual particles which adhere to one another or to the fibres of the carrier with only slight adhesive force after activation can then be released by means of an air jet and dispersed, to a large extent, into the lungs.
Instead of releasing the loosened powder from the carrier by means of a jet of air, it is also possible to loosen it by running an edge over it or by brushing, immediately before or while the flow of breathed-in air is passing the carrier, and thereby transferring the powder into the air which is breathed in.
Apart from the high degree of accuracy of metering, the application of a drop of suspension has the further advantage over the application of dry powder that the powder is protected from being released by acceleration (impact, vibrations) by the incrustation. The activation by running along an edge should only be carried out immediately before the powder is released for inhalation.
An apparatus for applying the drop of suspension according to the invention is diagrammatically shown in Figure 1. The suspension 1 is initially in the storage container 2. From there it flows through the line 3 to 7 a magnetic valve 4 and past the valve surfaces through the line 5 into the storage container 6. In the resting position the plunger 7 seals off the inlet port of the line 8 from which the suspension is applied to the carrier 11. At the sides, the suspension is able to flow past the plunger from the line 3 to the line When the plunger is pulled back by an electromagnet, it exposes the opening so that the suspension can reach the carrier 11. The suspension is pumped out of the container 6 by means of the pump 9 into the storage container 2. To ensure that the suspension in the storage container 2 is always at the same level, there is a connecting line 10 between these two storage containers, through which suspension can flow from storage container 2 into storage container 6 when the liquid level is higher than the entry port of this connecting line. The cross-section of the lines 3 and is made so small that the volume flow of suspension flowing through the two lines is less than the volume flow delivered by the pump 9. In the storage containers 2 and 6 are stirrers which keep the particles constantly suspended. For uniform metering, the magnetic valve 4 is controlled by an electronic timer. Details of the valve are illustrated in Figure 2.
II
I_ 8 Example of the application of the pharmaceutical composition as a suspension: A suspension of micronised fenoterol (proportion of fenoterol: 10 percent by weight) in dichloromethane with the addition of (0.1 percent by weight) lecithin was applied to velvet with a fibre length of 1.2 mm over the basic fabric, dropwise at spacings of about 10 mm and then dried. The powder was then activated by runninq an edge over it and blown out of the carrier with a gentle jet of compressed air.
The inhalable portion of the particles (particle diameter 5.8 gm) was 41.4% of the dosage expelled.
A relatively small amount of gas, e.g. 10 cc of air, forced through a 0.5 mm diameter nozzle, is sufficient to disperse (blcw out) the powder.
The gas jet required for dispersal can be produced in various ways, e.g. using a cylinder provided with a nozzle out of which air is forced by a spring-operated ton, or by means of conventional small C02 containers which can be used to generate pressure. Instead of a cylinder with a piston it is also possible to use bellows.
A simple device in which carriers charged according to the invention can be used is diagrammatically shown in Figures 3 and 4. The main constituents are two bobbins, one of which receives the charged strip whilst the other receives the used strip. The strip is guided over a panel, whilst being guided past an edge to activate the powder. Here, the jet of gas or air makes contact with the strip and carries the powder along.
The jet is generally released at a time when air is being breathed in through the mouthpiece. It is advisable to actuate the stream of gas or air by means of the air breathed in so as to coordinate the dispersal 7 t -9of the powder with the inhalation process.
Figure 3 shows an inhalation device viewed from in front. The carrier strip 12 with the powder, which is applied in individual dots at regular intervals on the strip, is unwound from the bobbin 13 and, once empty, wound onto the bobbin 14. By means of a transporting mechanism constructed in conventional manner, the strip is wound on, on each actuation of the device, by an amount such that a new spot arrives on the flat surface The flat surface 15 is located in a mouthpiece 16 through which the patient breathes in. The slot through which the carrier strip 12 is guided into the mouthpiece is somewhat narrower than the thickness of the carrier strip 12. The upper boundary of the slot is constructed as an edge for activating the powder. Air is passed onto the dot of powder through a nozzle from a cylinder 17 in which there is a piston subjected to spring pressure with a handle 18. The spring which urges the piston towards the flat surface 15 is biased by pulling the handle 18. The dispersing step is prepared by means of a locking mechanism 19 which can be released by pressing the knob 20. Whilst breathing in thrgh the mouthpiece 16 the patient presses the knob 20 and thus ensures that the piston propels the quantity of air contained in the cylinder through the nozzle onto the dot of powder, so that the powder is dispersed in the air breathed in.
Figure 4 diagrammatically shows the apparatus from the side, the mouthpiece 16 being shown in section. The nozzle 21 guides the jet of air out of the cylinder 17 onto the dot of powder.
The bobbins with the carrier are in this case contained in a cassette similar to that used in cassette recorders. Their movement is advantageously coupled with the movement of the handle 18, so that, each time the piston is put under tension, the carrying strip is moved on until the next dot reaches the flat surface 0O Instead of the cylinder and spring it is also possible to use a bellows or a CO 2 cartridge of conventional construction which releases a few cc of CO 2 every time the device is used, in order to generate a gas current, as mentioned above. The CO z is then again guided through a nozzle onto the carrier surface coated with powder. The volume of gas needed to disperse a quantity of powder required for therapeutic purposes is generally 3 to 20 cc (under normal conditions).
Nozzles are used which have a mouth shaped to suit the type of carrier. In the case of circular dots of powder, the nozzle has a small, preferably circular aperture. In the case of larger, powder-coated carrier surfaces, a slot-shaped or rectangular nozzle may be more appropriate. In this case, a larger quantity of gas is used, if necessary, in order to ensure the required speed of outflow.
The accuracy of metering was measured in a series of tests in which either (tests 1, 2, 3) a carrier strip was continuously coated by the application of dry powder and a sharply defined section of the strip was investigated in each case or else a strip was used in which only certain places had a coating of powder.
The following surface coatings and relative standard deviations were found: Material Surface Relative standard covering deviation 1. Velour-film 6.6 mg/cm 2 6.3% 2. Velvet 2.2 mg/cm 2 S3. Nicki 5.4 mg/cm 2 6.2% 4. Velour-film with individual circular dots of powder* 2.1 mg/dot 11.2% i When the powder was applied the carrier was covered j i I 11 with a perforated film. The perforations were 4 mm in diameter and spaced 10 to 15 mm apart. By improving the charge, the standard deviation could be reduced still further in subsequent tests.
For virtually completo dispersal on blowing out the powder, a relatively small amount of gas is sufficient, e.g. 10 cc of air which is forced through a 0.8 mm diameter nozzle (in the case of the dots of powder according to test number Excellent break-up is found.
As was established by means of the Andersen impactor using micronised fenoterol, 40% of the particles of the dosage expelled were in the particle size range below 5.8 Am.

Claims (10)

1. Powder-charged carrier which is charged with a powdered pharmaceutical and which comprises a substantially flat velvet- or velour-like material, and the powder is incorporated between fibres thereof.
2. Powder-charged carrier according to claim 1, characterised in that the fibre length is 0.1 to 3 mm.
3. Powder-charged carrier according to claim 1 or claim 2, characterised in that the substantially flat material which carries the fibres is flexible.
4. Powder-charged carrier according to claim 1 or claim 2, characterised in that the substantially flat material which carries the fibres is rigid. o 0 5. Powder-charged carrier according to any one of claims 1 to 4, characterised in that the entire carrier surface is uniformly charged with powder. o 6. Powder-charged carrier according to any one of claims 1 to 4, characterised in that only partial areas of the carrier are charged with powder, the Oo0oo° individual charged partial areas of the carrier each containing a single dose of a pharmaceutical substance.
7. Powder-charged carried according to any one of claims 1 to 6, characterised in tha the carrier is provided with a protective film on the powder- 0 if charged side or on both sides.
8. Process for metering powders for inhalation, characterised in that, by means of a gas jet, a defined amount of powder is blown out from a carrier according S235/950S6923.SPE,12' sk, D "Cf 13 to any one of claims I to 7 and dispersed in the air breathed in.
9. Process according to claim 8, characterised in that the area of the. carrier from which the powder is to be blown out is defined by a mask. Process fort producing a carrier according to any one of claims 1 to 7, characterised in that tl powder is uniformly dijstributed on the carrier and is incorporated ir the fibre layer in one or Tnore steps using a doctor blade. Ii. Process fdr producing a carrier according to any one of claims I to 7, characterised in that the powder is applied to the velvet- or velour-like carrier in the form of a small amount of a suspension and the suspending agent is evaporated off.
12. Process f'r metering powders for inhalation, characterised in that single doses of the powder are o applied to a c~rrier according to any one of claims 1 to a4,4 7 in the form Of a suspension, then activated after drying, blown out of the carrier by means of a gas jet and dispersed in the air breathed in. a a a
13. Process for metering powders for inhalation, characterised in that a single dose of the powder is released from phe carrier according to any one of claims I to 7 using a brush or by passing it over an edge and is dispersed in the breathed-in air travelling past without the additional action of a gas jet.
14. Process for producing a carrier for inhalation as claimed in cl~im iII substantially as hereinbefore described wit4 reference to Figure I or Figure 2. A L.Process for meterin'g powders for inhalation as cl.aimed in claim 8 or.l2,subztafltialJ.y a5 hereinbefore described with reference to the Example. DATED this 16th day of March 1995. BOEHRINGER INGELHEIM INTERNATIONAL GMBH By their Patent Attorneys: CALLINAN LAWRIE CIE me
AU80638/91A 1990-06-28 1991-06-21 Process and device for dosing powders Ceased AU661274B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4020571A DE4020571A1 (en) 1990-06-28 1990-06-28 Device for dosing small quantities of powder esp. for asthma - powder is held between fibres of velvet-like material and is delivered, e.g. as medication into patients inhaled breath, by jet of air
DE4020571 1990-06-28
DE4102793 1991-01-31
DE19914102793 DE4102793A1 (en) 1991-01-31 1991-01-31 Medication powder-dosing carrier
PCT/EP1991/001153 WO1992000115A1 (en) 1990-06-28 1991-06-21 Process and device for dosing powders

Publications (2)

Publication Number Publication Date
AU8063891A AU8063891A (en) 1992-01-23
AU661274B2 true AU661274B2 (en) 1995-07-20

Family

ID=25894544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80638/91A Ceased AU661274B2 (en) 1990-06-28 1991-06-21 Process and device for dosing powders

Country Status (24)

Country Link
EP (1) EP0536232B1 (en)
JP (1) JP3307389B2 (en)
KR (1) KR0179375B1 (en)
AT (1) ATE127353T1 (en)
AU (1) AU661274B2 (en)
CA (1) CA2086123C (en)
CZ (1) CZ283510B6 (en)
DE (1) DE59106431D1 (en)
DK (1) DK0536232T3 (en)
ES (1) ES2078530T3 (en)
FI (1) FI104410B (en)
GR (1) GR3017782T3 (en)
HU (1) HU216129B (en)
IE (1) IE69035B1 (en)
IL (1) IL98637A (en)
NO (1) NO304295B1 (en)
NZ (1) NZ238783A (en)
PL (1) PL165973B1 (en)
PT (1) PT98112B (en)
RU (1) RU2068274C1 (en)
SI (1) SI9111110B (en)
UA (1) UA27765C2 (en)
WO (1) WO1992000115A1 (en)
YU (1) YU48708B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
DE4142238A1 (en) * 1991-12-20 1993-06-24 Boehringer Ingelheim Kg POWDER INHALATOR WITH POWDER SUPPORT FROM REGULAR MICROSTRUCTURES
SE9203570D0 (en) * 1992-11-27 1992-11-27 Astra Ab INHALES FOR MULTIPLE USE
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
NZ296010A (en) * 1994-10-21 1998-10-28 Glaxo Wellcome Inc Medicament carrier with at least one carrier screen portion for a dry powder inhalator
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
GB9616047D0 (en) 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
GB2380472A (en) * 2000-06-05 2003-04-09 Nordson Corp Apparatus and methods for dispensing minute amounts of liquid
BRPI0620064A2 (en) 2005-12-22 2011-11-01 Philip Morris Prod inhaler device
CN108814979B (en) * 2018-04-17 2020-09-22 吉林省中医药科学院 A solid medicine feed ware for paediatrics
CN113650947B (en) * 2021-08-24 2022-10-18 王霞 Accurate medicine bottle of getting of traditional chinese medicine dripping pill

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643435B2 (en) * 1989-04-28 1993-11-18 Riker Laboratories, Inc. Dry powder inhalation device
AU644790B2 (en) * 1989-04-28 1993-12-23 Astra Aktiebolag Dry powder inhalation device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837040C2 (en) * 1978-08-24 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Liquid transport system for an inhalation device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643435B2 (en) * 1989-04-28 1993-11-18 Riker Laboratories, Inc. Dry powder inhalation device
AU644790B2 (en) * 1989-04-28 1993-12-23 Astra Aktiebolag Dry powder inhalation device

Also Published As

Publication number Publication date
EP0536232B1 (en) 1995-09-06
NO925010L (en) 1993-01-29
HU9204100D0 (en) 1993-05-28
FI104410B (en) 2000-01-31
HU216129B (en) 1999-04-28
RU2068274C1 (en) 1996-10-27
CA2086123C (en) 2002-01-01
DK0536232T3 (en) 1996-01-22
GR3017782T3 (en) 1996-01-31
EP0536232A1 (en) 1993-04-14
AU8063891A (en) 1992-01-23
PT98112A (en) 1993-09-30
IL98637A0 (en) 1992-07-15
NZ238783A (en) 1994-09-27
FI925882A0 (en) 1992-12-28
CZ283510B6 (en) 1998-04-15
PL165973B1 (en) 1995-03-31
KR930701206A (en) 1993-06-11
DE59106431D1 (en) 1995-10-12
FI925882A (en) 1992-12-28
SI9111110A (en) 1997-02-28
JP3307389B2 (en) 2002-07-24
NO304295B1 (en) 1998-11-30
KR0179375B1 (en) 1999-04-01
CA2086123A1 (en) 1991-12-29
PT98112B (en) 1998-12-31
SI9111110B (en) 1999-06-30
YU111091A (en) 1994-11-15
ES2078530T3 (en) 1995-12-16
YU48708B (en) 1999-07-28
IE912245A1 (en) 1992-01-01
HUT63775A (en) 1993-10-28
JPH05508334A (en) 1993-11-25
ATE127353T1 (en) 1995-09-15
WO1992000115A1 (en) 1992-01-09
UA27765C2 (en) 2000-10-16
IE69035B1 (en) 1996-08-07
IL98637A (en) 1998-01-04
CZ386192A3 (en) 1993-10-13
NO925010D0 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
AU661274B2 (en) Process and device for dosing powders
CA2157584C (en) Dry powder medicament inhalator
US5503869A (en) Process for forming medicament carrier for dry powder inhalator
US5823182A (en) Medicament carrier for dry powder inhalator
US6012454A (en) Dry powder inhalation device
EP0455463A1 (en) Packaging for microdoses of powdered medicament for inhalation
JPH04504671A (en) Powder inhalation device, elongated carrier for powdered drug, and cassette with elongated carrier
JPH0147190B2 (en)
JPH09504455A (en) Dry powder drug inhaler
DE4020571A1 (en) Device for dosing small quantities of powder esp. for asthma - powder is held between fibres of velvet-like material and is delivered, e.g. as medication into patients inhaled breath, by jet of air
EP0843566B1 (en) Medicament carrier for dry powder inhalator and process for forming the same
DE4102793A1 (en) Medication powder-dosing carrier
GB2300371A (en) Particulate dispenser
WO1996034642A1 (en) Particulate dispenser
AU1472099A (en) Medicament carrier for dry powder inhalator and process for forming the same